Evaluating the Impact on Clinician Diagnostic Confidence and Management Following Disclosure of Alzheimer's Disease Probability Informed by Plasma pTau181 Levels in Memory and Cognition Clinic Patients: A Before‐and‐After Study
This study highlights the potential of a blood test for AD in clinical practice, enhancing diagnostic accuracy in cases with low-to-moderate diagnostic confidence.
Authors
- Vincent Doré (ORCID: https://orcid.org/0000-0002-8051-0558)
- Johannes C. Michaelian (ORCID: https://orcid.org/0000-0001-5683-8222)
- James Clement Vickers (ORCID: https://orcid.org/0000-0001-5671-4879)
- Catriona Ireland (ORCID: https://orcid.org/0000-0002-7226-8466)
- Azadeh Feizpour
- Jane Alty (ORCID: https://orcid.org/0000-0002-5456-8676)
- Sharon L. Naismith (ORCID: https://orcid.org/0000-0001-9076-2778)
- Anna Elizabeth King (ORCID: https://orcid.org/0000-0003-1792-0965)
- C. Rowe
- Jessica M. Collins
- Michael Woodward
Institutions
- The University of Sydney (AU)
- University of Tasmania (AU)
- Australian e-Health Research Centre (AU)
- Austin Health (AU)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70856_099163
- Primary Topic
- Alzheimer's disease research and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00